[1]Abnet C C, Arnold M, Wei W Q. Epidemiology of esophageal squamous cell carcinoma[J]. Gastroenterology, 2018, 154(2): 360-373.
[2]Sun D, Li H, Cao M, et al. Cancer burden in China: trends, risk factors and prevention[J]. Cancer Biol Med,2020, 17(4): 879-895.
[3]Simba H, Kuivaniemi H, Lutje V, et al. Systematic review of genetic factors in the etiology of esophageal squamous cell carcinoma in African populations[J]. Front Genet, 2019, 10: 642.
[4]Li W, Hu J, Adebali O, et al. Human genome-wide repair map of DNA damage caused by the cigarette smoke carcinogen benzo[a]pyrene[J]. PNAS, 2017, 114(26): 6752-6757.
[5]Hakami R, Mohtadinia J, Etemadi A, et al. Dietary intake of benzo(a)pyrene and risk of esophageal cancer in north of Iran[J]. Nutr Cancer, 2008, 60(2): 216-221.
[6]Mantovani A, Allavena P, Marchesi F, et al. Macrophages as tools and targets in cancer therapy[J].Nat Rev Drug Discov, 2022, 21(11): 799-820.
[7]Christofides A, Strauss L, Yeo A, et al. The complex role of tumor-infiltrating macrophages[J].Nat Immunol, 2022, 23(8): 1148-1156.
[8]Cheng C, Wang P, Yang Y, et al. Smoking-induced M2-TAMs, via circEML4 in EVs, promote the progression of NSCLC through ALKBH5-regulated m6A modification of SOCS2 in NSCLC cells[J]. Adv Sci (Weinh), 2023: e2300953.
[9]Castro C, Peleteiro B, Lunet N. Modifiable factors and esophageal cancer: a systematic review of published meta-analyses[J]. J Gastroenterol, 2018, 53(1): 37-51.
[10]Qiu F, Liang C L, Liu H, et al. Impacts of cigarette smoking on immune responsiveness: up and down or upside down?[J]. Oncotarget, 2017, 8(1): 268-284.
[11]Wang G, Pan C, Cao K, et al. Impacts of cigarette smoking on the tumor immune microenvironment in esophageal squamous cell carcinoma[J]. J Cancer, 2022, 13(2): 413-425.
[12]Madeen E, Siddens L K, Uesugi S, et al. Toxicokinetics of benzo[a]pyrene in humans: extensive metabolism as determined by UPLC-accelerator mass spectrometry following oral micro-dosing[J]. Toxicol Appl Pharmacol, 2019, 364: 97-105.
[13]Wei Y, Zhao L, He W, et al. Benzo[a]pyrene promotes gastric cancer cell proliferation and metastasis likely through the aryl hydrocarbon receptor and ERK-dependent induction of MMP9 and c-myc[J]. Int J Oncol, 2016, 49(5): 2055-2063.
[14]Salem M L, El-ashmawy N E, Abd El-fattah E E, et al. Immunosuppressive role of benzo[a]pyrene in induction of lung cancer in mice[J]. Chem Biol Interact, 2021, 333: 109330.
[15]Wang H, Liu B, Chen H, et al. Dynamic changes of DNA methylation induced by benzo(a)pyrene in cancer[J]. Genes Environ, 2023, 45(1): 21.
[16]Mantovani A, Allavena P, Sica A, et al. Cancer-related inflammation[J]. Nature, 2008, 454(7203): 436-444.
[17]Liu Q, Tong D, Liu G, et al. Metformin inhibits prostate cancer progression by targeting tumor-associated inflammatory infiltration[J]. Clin Cancer Res, 2018, 24(22): 5622-5634.
[18]Mcneil J J, Nelson M R, Woods R L, et al. Effect of aspirin on all-cause mortality in the healthy elderly[J]. N Engl J Med, 2018, 379(16): 1519-1528.
[19]Meyerhardt J A, Shi Q, Fuchs C S, et al. Effect of celecoxib vs placebo added to standard adjuvant therapy on disease-free survival among patients with stage Ⅲ colon cancer: the CALGB/SWOG 80702 (alliance) randomized clinical trial[J]. JAMA, 2021, 325(13): 1277-1286.
|